[go: up one dir, main page]

SG149043A1 - N,n-dihalogenated amino acids and derivatives - Google Patents

N,n-dihalogenated amino acids and derivatives

Info

Publication number
SG149043A1
SG149043A1 SG200809398-1A SG2008093981A SG149043A1 SG 149043 A1 SG149043 A1 SG 149043A1 SG 2008093981 A SG2008093981 A SG 2008093981A SG 149043 A1 SG149043 A1 SG 149043A1
Authority
SG
Singapore
Prior art keywords
derivatives
amino acids
compositions
compounds
dihalogenated amino
Prior art date
Application number
SG200809398-1A
Other languages
English (en)
Inventor
Mansour Bassiri
Ramin Najafi
Lu Wang
Jane Yang
Original Assignee
Novacal Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novacal Pharmaceuticals Inc filed Critical Novacal Pharmaceuticals Inc
Publication of SG149043A1 publication Critical patent/SG149043A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/02—Compounds containing nitrogen-to-halogen bonds
    • C07C239/04—N-halogenated amines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/04—Sulfonic acids; Derivatives thereof
    • A01N41/08—Sulfonic acid halides; alpha-Hydroxy-sulfonic acids; Amino-sulfonic acids; Thiosulfonic acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
SG200809398-1A 2003-08-18 2004-08-17 N,n-dihalogenated amino acids and derivatives SG149043A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49620703P 2003-08-18 2003-08-18

Publications (1)

Publication Number Publication Date
SG149043A1 true SG149043A1 (en) 2009-01-29

Family

ID=34272488

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200809398-1A SG149043A1 (en) 2003-08-18 2004-08-17 N,n-dihalogenated amino acids and derivatives

Country Status (21)

Country Link
US (2) US7462361B2 (ja)
EP (2) EP1656095B1 (ja)
JP (1) JP4994033B2 (ja)
KR (1) KR101057609B1 (ja)
CN (1) CN1902158B (ja)
AR (1) AR047757A1 (ja)
AU (1) AU2004268546B2 (ja)
BR (1) BRPI0413660A (ja)
CA (1) CA2535926C (ja)
DK (1) DK1656095T3 (ja)
ES (1) ES2444845T3 (ja)
HK (1) HK1103713A1 (ja)
IL (1) IL173726A (ja)
MX (1) MXPA06001898A (ja)
NZ (1) NZ545654A (ja)
PL (1) PL1656095T3 (ja)
PT (1) PT1656095E (ja)
SG (1) SG149043A1 (ja)
SI (1) SI1656095T1 (ja)
TW (1) TWI376364B (ja)
WO (1) WO2005020896A2 (ja)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393522B2 (en) * 2000-01-12 2008-07-01 Novabay Pharmaceuticals, Inc. Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
JP5140218B2 (ja) 2001-09-14 2013-02-06 有限会社コヒーレントテクノロジー 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法
MXPA03007923A (es) 2001-12-05 2005-02-17 Micromed Lab Inc Metodo y aparato para producir agua potencial oxidativa reductiva positiva y negativa.
PT1656095E (pt) * 2003-08-18 2014-03-11 Novabay Pharmaceuticals Inc Aminoácidos n,n-dihalogenados e seus derivados
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
ES2701153T3 (es) 2005-03-23 2019-02-21 Sonoma Pharmaceuticals Inc Método para tratar úlceras de piel utilizando una solución con agua de potencial reductivo oxidativo
JP5907645B2 (ja) 2005-05-02 2016-04-26 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 歯科用途における酸化還元電位水溶液の使用法
AU2006302370B2 (en) * 2005-10-06 2012-06-14 Novabay Pharmaceuticals, Inc. System and method for the prevention of bacterial and fungal infections including urinary tract infections (UTI) using N-halogenated amino acids
WO2007085018A2 (en) 2006-01-20 2007-07-26 Oculus Innovative Sciences, Inc. Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
US20070292488A1 (en) * 2006-06-14 2007-12-20 Mansour Bassiri Method for treatment of wound treatment using aganocides
TW200843787A (en) * 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them
US20080287866A1 (en) * 2007-01-31 2008-11-20 Adam Heller Methods and compositions for the treatment of pain
UY31058A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
UY31056A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Fromulaciones aminocido n-halogenado y metodos de limpieza y desinfeccion
UY31059A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado
UY31057A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado que contiene acido alifatico
US7524512B2 (en) * 2007-07-13 2009-04-28 Di Bartolomeo Joseph R Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube
UY31055A1 (es) * 2008-02-01 2008-10-31 Alcon Res Ltd Sales antimicrobianas de aminoacido n-halogenado
US20110151025A1 (en) 2008-04-10 2011-06-23 Novabay Pharmaceuticals, Inc. Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections
CA2723262A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
EP2312939A4 (en) * 2008-08-12 2012-10-31 Novabay Pharmaceuticals Inc ANTIMICROBIAL GEL FORMULATIONS
JP5753785B2 (ja) * 2008-11-07 2015-07-22 ノバベイ・ファーマシューティカルズ・インコーポレイテッドＮｏｖａｂａｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 抗菌オキサゾリジノン、ヒダントインおよびイミダゾリジノン組成物
US8278482B2 (en) 2008-11-07 2012-10-02 Novabay Pharmaceuticals, Inc. Antimicrobial N-chlorinated compositions
US20100204181A1 (en) * 2009-02-06 2010-08-12 Alcon Research, Ltd. N-halogenated amino acid formulations comprising phosphine or amine oxides
WO2010126670A2 (en) * 2009-03-27 2010-11-04 Gojo Industries, Inc. Compositions and methods for screening and using compounds antagonizing spore-surface interactions
US20100272783A1 (en) * 2009-04-24 2010-10-28 Novabay Pharmaceuticals, Inc. Methods of Treating Infections of the Nail
JP6033082B2 (ja) 2009-06-15 2016-11-30 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 次亜塩素酸を含有する溶液及びその使用方法
SG182621A1 (en) * 2010-02-04 2012-08-30 Novabay Pharmaceuticals Inc Polysaccharide based antimicrobial formulations
JP2013545728A (ja) * 2010-10-19 2013-12-26 ノバベイ・ファーマシューティカルズ・インコーポレイテッド 抗菌性ポリエーテルおよびポリオール化合物
WO2012157699A1 (ja) * 2011-05-18 2012-11-22 味の素株式会社 動物用免疫賦活剤、それを含む飼料及びその製造方法
CA2837920A1 (en) 2011-06-15 2012-12-20 Rls Global Ab Detection and removal of carious dentin tissue
US9028807B2 (en) 2012-04-05 2015-05-12 Ues, Inc. Synthesis models for antimicrobial agents via the halogenation of organic/inorganic composites
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
CA3026576A1 (en) 2016-06-09 2017-12-14 Johnson Matthey Public Limited Company Electrolytic production of organic chloramine solutions
CA3089958A1 (en) * 2018-01-30 2019-08-08 Buckman Laboratories International, Inc. Synergistic combinations of monochloramine and organic acid, and methods of using the same for microbial control
CN111116406B (zh) * 2019-12-31 2020-12-25 吉林大学 一种能在物品表面形成杀菌涂层的卤胺及在物品表面形成杀菌涂层的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998945A (en) * 1972-06-12 1976-12-21 National Patent Development Corporation Dental treatment
US3950536A (en) * 1974-02-01 1976-04-13 Sol Joseph Barer N,N-Dichloro substituted aminocarboxylic acids as bactericides and fungicides
US4015008A (en) * 1974-02-01 1977-03-29 National Patent Development Corporation N,N-dichloro substituted aminocarboxylic acids as microbiocides
US4045578A (en) * 1974-06-14 1977-08-30 Interx Research Corporation N-chloro-amino acid derivatives exhibiting antibacterial activity
US3966796A (en) * 1974-06-14 1976-06-29 Interx Research Corporation N-chloro-amino acid derivatives activity
US4386103A (en) * 1981-01-30 1983-05-31 Merck & Co., Inc. Dichloroamino acid derivatives useful as potent germicidal and fungicidal agents
US5055492A (en) * 1985-06-14 1991-10-08 Masonic Medical Research Laboratory Method for affecting reproductive cycle of insects
US5096700A (en) * 1990-09-28 1992-03-17 The Procter & Gamble Company Halogenated aminohexanoates and aminobutyrates antimicrobial agents
DE4041703C2 (de) 1990-12-24 1993-10-21 Waldemar Dr Gottardi Alkalimetallsalze des N-Chlortaurins in kristalliner Form, Verfahren zu deren Herstellung und deren Verwendung
JP3759757B2 (ja) 1994-01-13 2006-03-29 相互薬工株式会社 殺菌剤
US5593714A (en) * 1994-12-06 1997-01-14 Hirsch; Gerald P. Method of pressure preservation of food products
US5753701A (en) * 1996-10-25 1998-05-19 University Of Kentucky N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection
DE19712565A1 (de) 1997-03-25 1998-10-01 Thomas W Dr Stief Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
DE19816102C1 (de) 1998-04-10 1999-09-16 Waldemar Gottardi Verfahren zum Inaktivieren von Viren in Proteinlösungen, Verwendung von N-Chlortaurin in dem Verfahren sowie nach dem Verfahren hergestellte Proteinlösungen
CA2320556A1 (en) 1999-09-29 2001-03-29 Queen's University At Kingston N,n-dichlorinated omega amino acids and uses thereof
ATE344662T1 (de) 2000-09-14 2006-11-15 Waldemar Gottardi Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
FR2819723B1 (fr) 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
PT1656095E (pt) * 2003-08-18 2014-03-11 Novabay Pharmaceuticals Inc Aminoácidos n,n-dihalogenados e seus derivados
WO2005061468A1 (en) * 2003-12-17 2005-07-07 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
TWI386201B (zh) 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
TW200843787A (en) 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them

Also Published As

Publication number Publication date
WO2005020896A2 (en) 2005-03-10
US20090023812A1 (en) 2009-01-22
PL1656095T3 (pl) 2014-04-30
TWI376364B (en) 2012-11-11
DK1656095T3 (en) 2014-03-10
EP1656095B1 (en) 2014-01-01
HK1103713A1 (ja) 2007-12-28
PT1656095E (pt) 2014-03-11
MXPA06001898A (es) 2006-05-31
EP1656095A4 (en) 2007-11-28
CN1902158A (zh) 2007-01-24
AU2004268546A1 (en) 2005-03-10
AR047757A1 (es) 2006-02-22
JP4994033B2 (ja) 2012-08-08
IL173726A0 (en) 2006-07-05
US7462361B2 (en) 2008-12-09
CA2535926A1 (en) 2005-03-10
CA2535926C (en) 2012-10-09
JP2007502826A (ja) 2007-02-15
CN1902158B (zh) 2011-04-06
US7893109B2 (en) 2011-02-22
US20050065115A1 (en) 2005-03-24
EP2725008A1 (en) 2014-04-30
KR101057609B1 (ko) 2011-08-18
NZ545654A (en) 2009-12-24
SI1656095T1 (sl) 2014-04-30
WO2005020896A3 (en) 2006-10-05
IL173726A (en) 2013-06-27
TW200520749A (en) 2005-07-01
BRPI0413660A (pt) 2006-10-24
KR20060065701A (ko) 2006-06-14
ES2444845T3 (es) 2014-02-27
EP1656095A2 (en) 2006-05-17
AU2004268546B2 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
SG149043A1 (en) N,n-dihalogenated amino acids and derivatives
TW200640445A (en) N-halogenated amino acids, N, N-dihalogenated amino acids and derivatives; compositions and methods of using them
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
TW200612939A (en) Antibiotics containing borinic acid complexes and methods of use
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2007067559A3 (en) Antibacterial agents
HK1138735A1 (en) Disinfectant
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
IT1317735B1 (it) Sali di agenti antimicrobici.
GB0710121D0 (en) Antifungal agents
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
MX2007000392A (es) Derivados de 2-pirrolidona sustituida como fungicidas e insecticidas.
ZA200809714B (en) Synergistic active ingredient combinations
MXPA02011039A (es) Combinaciones de productos activos fungicidas.
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2007125383A3 (en) Topical drug delivery by iontophoresis
ZA200508476B (en) Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent
MX2010001304A (es) Compuestos terapeuticos.
PL367074A1 (en) Bioregulatory combination of active agents
WO2012049327A3 (en) Pesticidal mixtures
WO2010014943A3 (en) Methionine analogs and methods of using same
TW200700421A (en) Novel triazolopyrimidine derivatives
WO2007079173A3 (en) Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents
TW200420561A (en) Antimicrobial 1-aryl dihydropyridone compounds